Lalanthica V. Yogendran

Neurology

1 Medical Village Dr
Edgewood, KY 41017

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Practical Management of Headaches in Patients With Primary and Secondary Brain Tumors.

Practical Management of Headaches in Patients With Primary and Secondary Brain Tumors.

Journal: Journal of pain and symptom management

Published: January 26, 2026

Practical management of headaches in patients with primary and secondary brain tumors.

Practical management of headaches in patients with primary and secondary brain tumors.

Journal: Journal of pain and symptom management

Published: January 26, 2026

Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature review.

Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature review.

Journal: Surgical neurology international

Published: January 05, 2026

An exploratory analysis of the association between progesterone use and tumor-related visual deficit in women with meningioma.

An exploratory analysis of the association between progesterone use and tumor-related visual deficit in women with meningioma.

Journal: International journal of radiation oncology, biology, physics

Published: December 18, 2025

Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis.

Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis.

Journal: Journal of neuro-oncology

Published: December 04, 2025

Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.

Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.

Journal: Journal of neuro-oncology

Published: March 29, 2025

Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells.

Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells.

Journal: Molecular cancer therapeutics

Published: March 15, 2025

Immune Checkpoint Inhibition for High Grade Meningiomas: A Systematic Review.

Immune Checkpoint Inhibition for High Grade Meningiomas: A Systematic Review.

Journal: World neurosurgery

Published: April 07, 2024

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance.

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance.

Journal: International journal of molecular sciences

Published: July 23, 2023

Navigating disability insurance in the American healthcare system for the low-grade glioma patient.

Navigating disability insurance in the American healthcare system for the low-grade glioma patient.

Journal: Neuro-oncology practice

Published: January 20, 2023

The landscape of brain tumor mimics in neuro-oncology practice.

The landscape of brain tumor mimics in neuro-oncology practice.

Journal: Journal of neuro-oncology

Published: June 11, 2022

Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma.

Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma.

Journal: Cells

Published: October 21, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026